Mark Jensen

Group Leader at SCYNEXIS - Jersey City, NJ, US

Mark Jensen's Colleagues at SCYNEXIS
Jim Maffezzoli

Vice President Marketing and Sales

Contact Jim Maffezzoli

Bob Rodebaugh

Director, Process Chemistry

Contact Bob Rodebaugh

Ghazala Kabani

Senior Director, Clinical Development and Operations

Contact Ghazala Kabani

Rossana PhD

Executive Director Marketing

Contact Rossana PhD

Kate Bennett

Associate Manager, Human Resources

Contact Kate Bennett

View All Mark Jensen's Colleagues
Mark Jensen's Contact Details
HQ
201-884-5485
Location
Company
SCYNEXIS
Mark Jensen's Company Details
SCYNEXIS logo, SCYNEXIS contact details

SCYNEXIS

Jersey City, NJ, US • 100 - 249 Employees
BioTech/Drugs

SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections. Our lead candidate, ibrexafungerp, is a broad-spectrum IV/oral antifungal agent representing a novel therapeutic class, that is in FDA review for the treatment of vaginal yeast infection also known as vulvovaginal candidiasis (VVC) and late-stage clinical development for multiple life-threatening fungal infections in hospitalized patients. The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization.

Antifungals Drug Development B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about SCYNEXIS
Frequently Asked Questions about Mark Jensen
Mark Jensen currently works for SCYNEXIS; Inc.
Mark Jensen's role at SCYNEXIS; Inc is Group Leader.
Mark Jensen's email address is ***@scynexis.com. To view Mark Jensen's full email address, please signup to ConnectPlex.
Mark Jensen works in the Biotechnology industry.
Mark Jensen's phone number is ["+12018845485"]
See more information about Mark Jensen